Rigel Pharmaceuticals Inc
RIGL- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001034842
No open-market purchases or sales by Rigel Pharmaceuticals Inc insiders were filed in the last 90 days; 155 institutions reported holding it in 13F filings for Q2 2026, worth $640.4M in total; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Rigel Pharmaceuticals Inc insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Rigel Pharmaceuticals Inc, current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Schorno Dean L | EVP & Chief Financial Officer | 82,962 | Sep 3, 2026 | 7 |
| Santos David A | EVP, Chief Commercial Officer | 61,622 | Sep 3, 2026 | 6 |
| Rodriguez Raul R | CEO, President | 273,362 | Sep 3, 2026 | 6 |
| Furey Raymond J. | EVP, GC, CCO & Corp Sec | 50,559 | Sep 3, 2026 | 6 |
| Hannah Alison L. | EVP, Chief Medical Officer | 35,025 | Jul 10, 2026 | 2 |
| Ali-Jackson Kamil | Director | 10,125 | Jun 24, 2026 | 3 |
| Rojkjaer Lisa | EVP, Chief Medical Officer | 34,003 | Jun 22, 2026 | 4 |
| Moos Walter H | Director | 18,472 | May 19, 2026 | 2 |
| Miller Michael Patrick | Director | 5,937 | May 19, 2026 | 2 |
| Lapointe Anthony Gregg | Director | 18,250 | May 19, 2026 | 1 |
| Wasman Jane | Director | 18,250 | May 19, 2026 | 1 |
| Frohlich Mark W | Director | 7,000 | May 19, 2026 | 1 |
| Kotzin Brian L. | Director | 100,000 | May 29, 2024 | 0 |
| Lyons Gary A | Director | 75,000 | Jul 12, 2023 | 0 |
| Dummer Wolfgang | EVP & CMO | 72,459 | Feb 6, 2023 | 0 |
| Vance Dolly | EVP Corp. Affairs, G.C., Sect. | 60,260 | Sep 16, 2022 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 24, 2026 (view filing) | Jun 22 | 2 days | Ali-Jackson KamilDirector | SSale | −2.50K | $35.00 | −$87.5K | −19.8%10.1K after | 10b5-1 |
| May 28, 2026 (view filing) | May 26 | 2 days | Ali-Jackson KamilDirector | SSale | −2.50K | $29.17 | −$72.9K | −16.5%12.6K after | 10b5-1 |
| Feb 24, 2026 (view filing) | Feb 20 | 4 days | Moos Walter HDirector | SSale | −4.00K | $36.36 | −$145.4K | −23.9%12.7K after | |
| Feb 6, 2025 (view filing) | Feb 4-5 | 2 days | Schorno Dean LEVP & Chief Financial Officer | SSale | −3.77K | $21.38 | −$80.6K | −6.2%57.2K after | 2 lots |
| Feb 6, 2025 (view filing) | Feb 4-5 | 2 days | Santos David AEVP, Chief Commercial Officer | SSale | −3.92K | $21.38 | −$83.8K | −7.0%51.7K after | 2 lots |
| Feb 6, 2025 (view filing) | Feb 4-5 | 2 days | Rodriguez Raul RCEO, President | SSale | −9.35K | $21.40 | −$200.1K | −3.8%239.5K after | 2 lots |
| Feb 6, 2025 (view filing) | Feb 4-5 | 2 days | Furey Raymond J.EVP, GC, CCO & Corp Sec | SSale | −2.79K | $21.41 | −$59.7K | −6.7%38.8K after | 2 lots |
| Feb 6, 2024 (view filing) | Feb 2-5 | 4 days | Santos David AEVP, Chief Commercial Officer | SSale | −14.5K | $1.14 | −$16.5K | −4.0%349.1K after | 2 lots |
| Feb 6, 2024 (view filing) | Feb 2-5 | 4 days | Schorno Dean LEVP & Chief Financial Officer | SSale | −12.6K | $1.14 | −$14.3K | −3.0%402.9K after | 2 lots |
| Feb 6, 2024 (view filing) | Feb 2-5 | 4 days | Rodriguez Raul RCEO, President | SSale | −52.9K | $1.14 | −$60.1K | −2.5%2.04M after | 2 lots |
| Feb 7, 2023 (view filing) | Feb 6 | 1 day | Rodriguez Raul RCEO, President | SSale | −20.3K | $1.75 | −$35.6K | −1.2%1.68M after | |
| Feb 6, 2023 (view filing) | Feb 2 | 4 days | Santos David AEVP, Chief Commercial Officer | SSale | −5.39K | $1.66 | −$8.94K | −3.6%144.6K after | |
| Feb 6, 2023 (view filing) | Feb 2 | 4 days | Schorno Dean LEVP & Chief Financial Officer | SSale | −5.39K | $1.66 | −$8.95K | −2.7%196.5K after | |
| Feb 6, 2023 (view filing) | Feb 2 | 4 days | Dummer WolfgangEVP & CMO | SSale | −5.39K | $1.66 | −$8.95K | −6.9%72.5K after | |
| Jun 13, 2022 (view filing) | Jun 9 | 4 days | Rodriguez Raul RCEO, President | PPurchase | +1.00M | $0.69 | +$690.0K | +255.2%1.39M after |